Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.
By
Maria Ressa built a successful media startup — and exposed human rights issues — while fighting disinformation and attacks from the Philippine government.
We offer a portfolio of programs that support students at every stage of their entrepreneurial journey.
HSI Professor Joseph Doyle is interviewed on Freakomomics, M.D. podcast
By
Legatum Center event will focus on development, entrepreneurship and finance
Members of the Student Sloan Healthcare Club are always responsible for this conference, but this year, the 19th, presented new complications since the event was held entirely online.
By
MIT Sloan School of Management’s Initiative for Health Systems Innovation (HSI) recently announced a formal collaboration with the Staten Island Performing Provider System (SI PPS).
By
“Building Sustainable Healthcare Systems through Innovation and Entrepreneurship” will bring together entrepreneurs, academics, healthcare professionals and policymakers from around the world.
